Abstract:ObjectiveGout is a widespread inflammatory arthritis. The present study aimed to identify potential biomarkers of gout and explore their underlying mechanisms through bioinformatics methods.MethodsThe microarray data was downloaded from the GSE160170 dataset from the Gene Expression Omnibus (GEO) database, and the GEO2R online tool was used to obtain differentially expressed genes (DEGs). We searched for gout-related genes through the DisGeNET and GeneCards databases, and the final DEGs was acquired by intersection with the DEGs obtained from the microarray dataset. Tissue- and organ-specific genes were identified by the BioGPS online tool. Enrichment analysis was performed using GSEA4.1.0 and KOBAS3.0, and a protein-protein interaction (PPI) network was constructed using STRING to understand the biological functions and enrichment pathways of the DEGs as well as to identify their hub genes. Cytoscape was used to construct the competitive endogenous RNA (ceRNA) networks.ResultsA total of 653 differentially expressed lncRNAs (DElncRNAs) and 818 differentially expressed mRNAs (DEmRNAs) were identified in the present study. After intersecting the differential DEGs from the dataset, 85 DEGs were obtained. Enrichment analyses showed that the DEGs were mainly enriched in the following biological processes (BPs): inflammation and regulation; immune response; and cell proliferation and apoptosis. Moreover, the DEGs were mainly enriched in rheumatoid arthritis (RA), osteoclast differentiation, interleukin (IL)-17 signaling pathway, nuclear factor kappa B (NF-κB) signaling pathway, Toll-like receptor signaling pathway and tumor necrosis factor (TNF) signaling pathway. Cytoscape software identified 15 hub genes, and the following 9 hub genes were obtained after intersecting with genes specifically expressed in the blood/immune and bone/muscle systems: TNF, JUN, PTGS2, STAT1, IL6, FOS, IL1β, CXCL8 and CD80. In addition, the lncRNA-NEAT1-miR-142-3p-IL-6 pathway may be a key regulatory pathway in the pathogenesis of gout.ConclusionsThe present study indicated that the identified 9 hub genes may be potential biomarkers for the diagnosis and treatment of gout. In addition, the results suggested that the lncRNA-NEAT1-miR-142-3p-IL-6 pathway may be a potential RNA regulatory pathway that controls the progression of gout disease.

Study on gout-specific local gene network and its relationship with nutrient metabolism modules

The relationship between metabolites and gout: a Mendelian randomization study

Identification of key genes in gout and atherosclerosis and construction of molecular regulatory networks

Identification of potential biomarkers of gout through weighted gene correlation network analysis

Local Gene Network Pattern (LGNP) Approach to Tackle Mechanisms of Complicated Phenotypes

Molecular Association Between Diabetes-Specific Local Gene Network and Nutrient Metabolism Modules

Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms

Specific blood metabolite associations with Gout: a Mendelian randomization study

A genome-wide association analysis reveals new pathogenic pathways in gout*

Identification of potential biomarkers of gout through competitive endogenous RNA network analysis

Enrichment analysis and chromosomal distribution of gout susceptible loci identified by genome-wide association studies

Single-cell and genome-wide Mendelian randomization identifies causative genes for gout

Assessing the causal association between human blood metabolites and the risk of gout

Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout

Identification of hub genes and transcription factors in patients with primary gout complicated with atherosclerosis

A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout

Identification of Inflammation-Related Biomarker Pro-ADM for Male Patients With Gout by Comprehensive Analysis

The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies

Untargeted metabolomics analysis of the urinary metabolic signature of acute and chronic gout

Metagenomic analysis revealed the potential role of gut microbiome in gout

Analysis of the relationship of refractory gout between potential biomarkers and diet structure and lifestyle based on 1H-NMR